Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-259890 |
|
|
Homo sapiens |
Colorectal Cancer Cell |
pmid |
sentence |
16336752 |
Cetuximab binds to domain III of EGFR and hinders ligand binding. It is now approved by the US Food and Drug Administration for metastatic colorectal cancer treatment. |
|